Work

CML-709: Co-Existing Myeloid Mutations at Diagnosis Are Associated With Increased Tyrosine Kinase Inhibitor Utilization in Chronic Phase CML

Year: 2026

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(26)02171-3

Authors: Umar Iqbal, Akriti Jain, Tod Knepper, Jinming Song, Ling Zhang, Rory Shallis, Andrew Kuykendall, Seongseok Yun, Sam B Reynolds, Alison R Walker, Jeffrey Lancet, Rami Komrokji, David Sallman, Eric Padron, Javier Pinilla, Onyee Chan, Kendra Sweet, Zhuoer Xie

Institutions: Moffitt Cancer Center, Cleveland Clinic

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7204711147

Cites:

Cited by:

Related to: 10